REMONT, Calif. and MOUNTAIN VIEW, Calif. /PRNewswire/ — WaferGen Bio-systems, Inc. (NASDAQ: WGBS), a publicly held genomics technology company (“WaferGen”), and Takara Bio USA Holdings, Inc. (“TBUSH”), announced Friday that they have entered into a merger agreement pursuant to which TBUSH ...
Read More »WaferGen Establishes Proof-of-Concept with SmartChip™-Based Single Cell RNA Sequencing Technology
FREMONT, Calif., Feb. 3, 2015 /PRNewswire/ — WaferGen Bio-systems, (NASDAQ: WGBS) announced today successful proof-of-concept of its single cell technology, which is based on the Company’s proprietary SmartChipTM platform. WaferGen’s scientists have successfully isolated single cells and produced excellent results in ...
Read More »Industry Press from ASHG Day 1
10:00 ET New England Biolabs® and Directed Genomics Partner to Develop Novel Target Enrichment Technologies for Next Generation Sequencing New England Biolabs (NEB®) and Directed Genomics together announce that they have established a partnership to develop a suite of new ...
Read More »WaferGen Bio-systems Acquires a Leading Next-Generation Sequencing (NGS) Library Preparation Business and Announces Changes to its Board of Directors
Acquisition propels the Company to being a major player in the NGS sample prep market FREMONT, Calif., January 7, 2014 /PRNewswire/ — WaferGen Bio-systems, Inc. (QTCQB: WGBS) announced today the acquisition of the NGS library preparation business from IntegenX Inc. ...
Read More »